REAL-WORLD USE OF SACUBITRIL-VALSARTAN IN THE SOUTH OF ENGLAND

被引：0
作者：
Dimarco, Anthony [1 ]
Haydock, Paul [2 ]
Flett, Andrew [2 ]
Cowburn, Peter [2 ]
Chandrasekaran, Badrinathan [3 ]
Foley, Paul [3 ]
Dixon, Giles [3 ]
Jackson, Thomas [4 ]
Critoph, Chris [5 ]
Davis, Hannah [5 ]
Kelly, Dominic [6 ]
机构：
[1] Barts Heart Ctr, London, England
[2] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England
[3] Great Western Hosp NHS Fdn Trust, Swindon, Wilts, England
[4] Salisbury NHS Fdn Trust, Salisbury, Wilts, England
[5] Royal Bournemouth & Christchurch Hosp NHS Fdn Tru, Bournemouth, Dorset, England
[6] Hampshire Hosp NHS Fdn Trust, Basingstoke, Hants, England
来源：
HEART | 2020年 / 106卷
关键词：
D O I：
10.1136/heartjnl-2020-BCS.94
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
94
引用
收藏
页码：A72 / A73
页数：4
相关论文
共 50 条
  • [41] Impact of Sacubitril-Valsartan on Markers of Glomerular Function
    Gregorio Tersalvi
    Jeroen Dauw
    Pieter Martens
    Wilfried Mullens
    Current Heart Failure Reports, 2020, 17 : 145 - 152
  • [42] Early experience of Sacubitril-Valsartan in heart failure with reduced ejection fraction in real-world clinical setting (vol 7, pg 1049, 2020)
    Backelin, C. Nordberg
    Fu, M.
    Ljungman, C.
    ESC HEART FAILURE, 2025, 12 (02): : 1525 - 1525
  • [43] Sacubitril-valsartan and its effect on ventricular remodeling
    Abellas Sequeiros, M. Maria
    Del Prado, S.
    Alonso Salinas, G.
    Lorente Ros, A.
    Vieitez Florez, J. M.
    Moya Mur, J. L.
    Garcia Martin, A.
    Jimenez Nacher, J. J.
    Fernandez Golfin, C.
    Zamorano Gomez, J. L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 236 - 236
  • [44] Predictors of maximal dose titration of Sacubitril-valsartan
    Rodrigues, T. E. Graca
    Agostinho, J. R.
    Pereira, S. Couto
    Silverio-Antonio, P.
    Brito, J.
    Da Silva, P. Alves
    Silva, B. Valente
    Cunha, N.
    Garcia, B.
    Rigueira, J.
    Lousada, N.
    Silva, D.
    Pinto, F. J.
    Brito, D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 136 - 136
  • [45] Sacubitril-valsartan and the evolution of heart failure care
    Starling, Randall C.
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2015, 82 (10) : 702 - 704
  • [46] Ventricular Stability with Sacubitril-Valsartan: For the Many, Not the Few
    Weir, RobinA. P.
    CARDIOLOGY, 2019, 143 (1-2) : 36 - 36
  • [47] Troponin reduction following Sacubitril-Valsartan therapy
    Antonio Amadeu Valentim Goncalves, A.
    Pereira-Da-Silva, T.
    Galrinho, A.
    Reis, J.
    Soares, R.
    Ilhao Moreira, R.
    Mano, T.
    Mendonca, T.
    Bras, P.
    Ferreira, V.
    Castelo, A.
    Viegas, J.
    Cruz Ferreira, R.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 52 - 52
  • [48] Sacubitril-valsartan in heart failure and multimorbidity patients
    Rodil Fraile, Raquel
    Malafarina, Vincenzo
    Tiberio Lopez, Gregorio
    ESC HEART FAILURE, 2018, 5 (05): : 957 - 960
  • [49] Heart Failure: Benefit from Sacubitril-Valsartan
    不详
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2024, 149 (20) : 1183 - 1183
  • [50] PIONEERing the In-Hospital Initiation of Sacubitril-Valsartan
    Jarcho, John
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (06) : 590 - 591
12345